In this issue:
Belimumab shows promise in SLE
Leflunomide in NZ clinical practice
Methotrexate pneumonitis: trends in NZ
Efficacy of IAHA in managing OA
Predictors of lymphoma development in pSS
Rituximab after failure of a single TNF-α inhibitor
Adalimumab + cyclosporine for severe PsA
Rituximab in pSS with PNS involvement
US-guided injection superior in OA knee
Treatment-to-target preferable with rituximab?
Please login below to download this issue (PDF)